Shots:Hikma has acquired the Novugen's US FDA ANDA approved trametinibtablets and also entered into a commercial agreement with NovugenUnder the agreement, Hikma will be responsible for all the US sales and marketing of trametinib while Novugen will manufacture and supply them to Hikma. Furthermore, when product is launched Hikma will have 180 days…
